HSIC · Henry Schein Inc - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.37B | - | $3.34B | $3.24B | $3.17B | - | $3.17B | $3.14B | $3.17B | - |
| Cost of Revenue | $2.30B | - | $2.31B | $2.22B | $2.17B | - | $2.18B | $2.12B | $2.16B | - |
| Gross Profit | $1.07B | - | $1.03B | $1.02B | $1.00B | - | $993.00M | $1.02B | $1.01B | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $809.00M | - | $760.00M | $778.00M | $738.00M | - | $724.00M | $781.00M | $791.00M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $81.00M | - | $80.00M | $64.00M | $73.00M | - | $64.00M | $63.00M | $73.00M | - |
| Operating Income | $182.00M | - | $164.00M | $151.00M | $175.00M | - | $157.00M | $159.00M | $150.00M | - |
| Interest Expense | $39.00M | - | $38.00M | $38.00M | $35.00M | - | $34.00M | $32.00M | $30.00M | - |
| Income Tax | $38.00M | - | $28.00M | $31.00M | $35.00M | - | $32.00M | $33.00M | $32.00M | - |
| Net Income | $107.00M | - | $101.00M | $86.00M | $110.00M | - | $99.00M | $104.00M | $93.00M | - |
| EPS - Basic | $0.93 | - | $0.84 | $0.71 | $0.89 | - | $0.79 | $0.81 | $0.72 | - |
| EPS - Diluted | $0.92 | - | $0.84 | $0.70 | $0.88 | - | $0.78 | $0.80 | $0.72 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $138.00M | $156.00M | $136.00M | $145.00M | $127.00M | $122.00M | $126.00M | $138.00M | $159.00M | $171.00M |
| Accounts Receivable | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B | $1.66B | $1.56B | $1.64B | $1.86B |
| Inventory | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B | $1.75B | $1.66B | $1.69B | $1.81B |
| Accounts Payable | $1.04B | $1.15B | $1.03B | $918.00M | $908.00M | $962.00M | $1.03B | $867.00M | $879.00M | $1.02B |
| Current Assets | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B | $4.15B | $3.94B | $4.08B | $4.49B |
| Total Assets | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | $10.57B |
| Current Liabilities | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B | $2.93B | $2.55B | $2.33B | $2.68B |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | $5.42B |
| Stockholders' Equity | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | $3.65B |
| Retained Earnings | $3.29B | $3.29B | $3.38B | $3.48B | $3.63B | $3.77B | $3.77B | $3.80B | $3.84B | $3.86B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($97.00M) | - | - | - | $37.00M | - | - | - | $197.00M | - |
| Investing Cash Flow | ($63.00M) | - | - | - | ($99.00M) | - | - | - | ($72.00M) | - |
| Financing Cash Flow | $120.00M | - | - | - | $89.00M | - | - | - | ($151.00M) | - |
| CapEx | $25.00M | - | - | - | $31.00M | - | - | - | $41.00M | - |
| Free Cash Flow | ($122.00M) | - | - | - | $6.00M | - | - | - | $156.00M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 31.8% | - | 30.7% | 31.4% | 31.6% | - | 31.3% | 32.5% | 31.9% | - |
| Operating margin | 5.4% | - | 4.9% | 4.7% | 5.5% | - | 4.9% | 5.1% | 4.7% | - |
| EBITDA margin | 7.8% | - | 7.3% | 6.6% | 7.8% | - | 7.0% | 7.1% | 7.0% | - |
| Net margin | 3.2% | - | 3.0% | 2.7% | 3.5% | - | 3.1% | 3.3% | 2.9% | - |
| Free cash flow margin | -3.6% | - | - | - | 0.2% | - | - | - | 4.9% | - |
| FCF / Net income | -1.14 | - | - | - | 0.05 | - | - | - | 1.68 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 24.0% | - | 22.8% | 24.0% | 23.3% | - | 22.8% | 24.9% | 24.9% | - |
| Effective tax rate | 26.2% | - | 21.7% | 26.5% | 24.1% | - | 24.4% | 24.1% | 25.6% | - |
| Return on assets | 0.9% | - | 0.9% | 0.8% | 1.0% | - | 0.9% | 1.0% | 0.9% | - |
| Return on equity | 3.3% | - | 3.0% | 2.5% | 3.3% | - | 2.8% | 3.0% | 2.6% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.36 | 1.38 | 1.40 | 1.41 | 1.38 | 1.42 | 1.42 | 1.55 | 1.75 | 1.67 |
| Quick ratio | 0.75 | 0.76 | 0.79 | 0.78 | 0.75 | 0.78 | 0.82 | 0.90 | 1.02 | 1.00 |
| Cash ratio | 0.04 | 0.05 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.05 | 0.07 | 0.06 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | 4.7x | - | 4.3x | 4.0x | 5.0x | - | 4.6x | 5.0x | 5.0x | - |
| Equity multiplier | 3.46 | 3.46 | 3.30 | 3.17 | 3.17 | 3.01 | 3.03 | 2.92 | 2.82 | 2.89 |
| Liabilities / Assets | 0.57 | 0.57 | 0.56 | 0.55 | 0.55 | 0.53 | 0.53 | 0.51 | 0.50 | 0.51 |
| Efficiency | ||||||||||
| Asset turnover | 0.30 | - | 0.30 | 0.30 | 0.30 | - | 0.30 | 0.31 | 0.31 | - |
| Inventory turnover | 1.14 | - | 1.21 | 1.17 | 1.18 | - | 1.24 | 1.28 | 1.28 | - |
| Days sales outstanding | 186d | - | 191d | 185d | 182d | - | 191d | 181d | 189d | - |
| Days inventory outstanding | 320d | - | 302d | 313d | 310d | - | 294d | 286d | 285d | - |
| Days payable outstanding | 166d | - | 163d | 151d | 153d | - | 172d | 149d | 149d | - |
| Cash conversion cycle | 341d | - | 329d | 348d | 339d | - | 313d | 318d | 326d | - |
| Valuation | ||||||||||
| P / E | 78.4x | - | 78.6x | 104.7x | 78.0x | - | 93.9x | 80.1x | 104.9x | - |
| P / B | 2.6x | - | 2.4x | 2.6x | 2.6x | - | 2.7x | 2.3x | 2.7x | - |
| P / S | 2.5x | - | 2.4x | 2.8x | 2.7x | - | 2.9x | 2.6x | 3.1x | - |
| EV / EBITDA | 31.3x | - | 32.2x | 41.1x | 34.0x | - | 41.5x | 36.5x | 43.2x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 6.3% | - | 5.2% | 3.3% | -0.1% | - | 0.4% | 1.2% | 3.7% | - |
| Revenue CAGR (3y) | 3.2% | - | 2.9% | 2.3% | -0.1% | - | -0.0% | 1.9% | 2.7% | - |
| Revenue CAGR (5y) | 2.9% | - | 3.3% | 14.0% | 5.5% | - | 4.8% | 5.1% | 6.1% | - |
| Gross profit growth (YoY) | 7.0% | - | 3.3% | -0.2% | -1.2% | - | -0.2% | 4.4% | 4.8% | - |
| Operating income growth (YoY) | 4.0% | - | 4.5% | -5.0% | 16.7% | - | -21.5% | -20.9% | -14.3% | - |
| Net income growth (YoY) | -2.7% | - | 2.0% | -17.3% | 18.3% | - | -27.7% | -25.7% | -23.1% | - |
| EPS growth (YoY) | 4.5% | - | 7.7% | -12.5% | 22.2% | - | -25.7% | -24.5% | -20.9% | - |
| EPS CAGR (3y) | 0.4% | - | -8.3% | -15.5% | -12.2% | - | -12.1% | -10.1% | -14.7% | - |
| EPS CAGR (5y) | -4.5% | - | -3.2% | - | -0.7% | - | -3.9% | 0.8% | -0.3% | - |
| FCF growth (YoY) | - | - | - | - | -96.2% | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | -38.4% | - | - | - | - | - |
| Book value growth (YoY) | -1.3% | -4.4% | -4.1% | -1.9% | -8.1% | -7.2% | -4.1% | -1.3% | 3.7% | 6.1% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-27.
Business segments
$7.05B totalGlobal Distribution And Value Added Services$4.83B · 68.5%
Global Specialty Products$1.54B · 21.9%
Global Technology$675.00M · 9.6%
Geographic
$13.18B totalUS$9.10B · 69.0%
Non Us$4.09B · 31.0%
Peer comparison
Same SIC group: Wholesale-Medical, Dental & Hospital Equipment & Supplies
Comparing HENRY SCHEIN INC against the 2 most active filers in the same SIC group.